gliclazide has been researched along with Hyperprolactinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, G; Jia, D; Lu, J; Wang, C; Wang, D; Zhang, Y; Zhang, ZJ | 1 |
1 other study(ies) available for gliclazide and Hyperprolactinemia
| Article | Year |
|---|---|
18β-Glycyrrhetinic Acid, a Novel Naturally Derived Agent, Suppresses Prolactin Hyperactivity and Reduces Antipsychotic-Induced Hyperprolactinemia in In Vitro and In Vivo Models.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Glycyrrhetinic Acid; Hyperprolactinemia; Prolactin; Rats; Receptors, Dopamine D2 | 2016 |